HONSUN(BJ:832278) Zhong Guo Jing Ji Wang·2025-09-09 03:16Group 1 - The core point of the news is that major shareholders and actual controllers of Lude Medical plan to reduce their holdings in the company, which may impact investor sentiment and stock performance [1][2] - Xiang Guoqiang, a major shareholder and actual controller, intends to reduce his holdings by 2,480,000 shares, accounting for 1.4212% of the total share capital, with the reduction period starting 15 trading days after the announcement until December 24, 2025 [1] - As of the announcement date, Xiang Guoqiang holds 10,238,400 shares, representing 5.8673% of the company [1] Group 2 - In addition to Xiang Guoqiang's planned reduction, another director, Zhu Wenjun, also intends to reduce his holdings by 1,000,000 shares, which is 0.5682% of the total share capital, within three months after a 30 trading day period following the announcement [1] - The actual controllers of Lude Medical are Xiang Youliang, Huang Jiejing, and Xiang Guoqiang, with Xiang Youliang and Xiang Guoqiang being Chinese nationals [2] - Shanghai Lujing Investment Management Center (Limited Partnership), an entity associated with the actual controllers, completed a reduction of 2,200,000 shares, representing 1.2500% of the total share capital, between May 30 and June 4, 2025, at a price range of 10.41 to 11.25 yuan per share, totaling approximately 23.76 million yuan [2]